1. Home
  2. BYON vs MBX Comparison

BYON vs MBX Comparison

Compare BYON & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • MBX
  • Stock Information
  • Founded
  • BYON 1997
  • MBX 2018
  • Country
  • BYON United States
  • MBX United States
  • Employees
  • BYON N/A
  • MBX N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • MBX
  • Sector
  • BYON Consumer Discretionary
  • MBX
  • Exchange
  • BYON Nasdaq
  • MBX NYSE
  • Market Cap
  • BYON 354.2M
  • MBX 379.7M
  • IPO Year
  • BYON N/A
  • MBX 2024
  • Fundamental
  • Price
  • BYON $6.02
  • MBX $9.63
  • Analyst Decision
  • BYON Hold
  • MBX Strong Buy
  • Analyst Count
  • BYON 8
  • MBX 5
  • Target Price
  • BYON $10.67
  • MBX $37.40
  • AVG Volume (30 Days)
  • BYON 2.6M
  • MBX 227.0K
  • Earning Date
  • BYON 07-28-2025
  • MBX 08-16-2025
  • Dividend Yield
  • BYON N/A
  • MBX N/A
  • EPS Growth
  • BYON N/A
  • MBX N/A
  • EPS
  • BYON N/A
  • MBX N/A
  • Revenue
  • BYON $1,244,431,000.00
  • MBX N/A
  • Revenue This Year
  • BYON N/A
  • MBX N/A
  • Revenue Next Year
  • BYON $12.55
  • MBX N/A
  • P/E Ratio
  • BYON N/A
  • MBX N/A
  • Revenue Growth
  • BYON N/A
  • MBX N/A
  • 52 Week Low
  • BYON $3.54
  • MBX $4.81
  • 52 Week High
  • BYON $15.44
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • BYON 48.05
  • MBX N/A
  • Support Level
  • BYON $6.27
  • MBX N/A
  • Resistance Level
  • BYON $6.52
  • MBX N/A
  • Average True Range (ATR)
  • BYON 0.48
  • MBX 0.00
  • MACD
  • BYON -0.13
  • MBX 0.00
  • Stochastic Oscillator
  • BYON 12.83
  • MBX 0.00

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: